Stock REGULUS THERAPEUTICS INC
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Calendar Regulus Therapeutics Inc Nasdaq

Equities

US75915K1016

Chart calendar Regulus Therapeutics Inc

7.wNU3oddV1AYgM3N7cSRPlbgHOjO7-6YkfXJnTJb-rS0.9INa0LIHgkp3UgINHwkg2fUxVGb6lfFHLwEEFtyf22Tt40fGliPtMhFiSw~92608f38e0bbad1ea409a568da217ef2

Upcoming events on Regulus Therapeutics Inc

08/05/2024 Q1 2024 Earnings Release (Projected)
16/05/2024 17:00 Annual General Meeting
07/08/2024 Q2 2024 Earnings Release (Projected)
06/11/2024 Q3 2024 Earnings Release (Projected)
07/05/2025 Q1 2025 Earnings Release (Projected)

Past events on Regulus Therapeutics Inc

01/05/2024 18:00 Canaccord Genuity Genetic Medicine for Generalists Webcast Series
21/03/2024 20:05 Q4 2023 Earnings Release
12/03/2024 12:30 Business Update Call
04/01/2024 Investor Meeting After hours
29/11/2023 15:25 Evercore ISI HealthCONx Conference
09/11/2023 21:05 Q3 2023 Earnings Release
20/09/2023 13:30 RGLS8429 Phase 1b Study Results Call
11/09/2023 16:00 H.C. Wainwright Global Investment Conference
06/09/2023 16:00 R&D Day
05/09/2023 Wells Fargo Healthcare Conference
09/08/2023 16:30 Canaccord Genuity Growth Conference
08/08/2023 21:05 Q2 2023 Earnings Release
25/07/2023 20:00 H.C. Wainwright Kidney Conference
01/06/2023 17:00 Annual General Meeting
11/05/2023 21:05 Q1 2023 Earnings Release
23/03/2023 20:05 Q4 2022 Earnings Release
08/03/2023 Chronic Kidney Disease Drug Development Summit
16/02/2023 18:00 SVB Securities Global Biopharma Conference
10/11/2022 22:00 Q3 2022 Earnings Call
10/11/2022 21:05 Q3 2022 Earnings Release

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million USD		Released
Forecast
Spread 		6,83
6,86
-0.38%		10,0
5,02
99.28%		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
-
0,00

EBITDA
Million USD		Released
Forecast
Spread 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		-30,9
-30,7
-0.59%
-38,7

EBIT
Million USD		Released
Forecast
Spread 		-16,8
-17,2
2.18%		-14,2
-19,2
26.36%		-27,8
-27,4
-1.42%		-28,2
-28,9
2.15%		-31,1
-30,9
-0.82%
-34,9

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		-18,6
-18,9
1.85%		-15,7
-20,9
24.88%		-27,8
-26,9
-3.43%		-28,3
-29,1
2.67%		-30,0
-29,9
-0.47%
-34,4

Net income
Million USD		Released
Forecast
Spread 		-18,6
-18,9
1.85%		-15,7
-20,9
24.86%		-27,8
-26,9
-3.43%		-28,3
-29,1
2.67%		-30,0
-30,0
-0.13%
-33,7

EPS
USD		Released
Forecast
Spread 		-10,8
-11,0
1.82%		-4,50
-6,60
31.82%		-3,20
-3,27
2.04%		-1,86
-1,83
-1.82%		-1,58
-1,59
0.32%
-0,51

Announcement Date12/03/2009/03/2110/03/2223/03/2321/03/24-

Quarterly results

Fiscal PeriodDecember 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1
Net sales
Million USD		Released
Forecast
Spread 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
-
0,00


0,00


0,00


0,00


0,00

EBIT
Million USD		Released
Forecast
Spread 		-6,96
-6,57
-5.9%		-6,57
-7,21
8.84%		-7,18
-7,05
-1.77%		-7,56
-7,35
-2.9%		-6,93
-7,66
9.5%		-7,37
-7,08
-4.16%		-7,32
-7,51
2.55%		-8,13
-7,51
-8.19%		-8,30
-8,05
-3.11%
-8,70


-8,70


-9,55


-9,55




Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		-7,13
-6,14
-16.24%		-6,72
-7,20
6.75%		-7,26
-7,14
-1.67%		-7,55
-7,39
-2.13%		-6,80
-7,70
11.75%		-7,14
-6,99
-2.1%		-7,01
-7,34
4.41%		-7,82
-7,31
-6.99%		-8,06
-7,91
-1.94%
-8,56


-8,46


-9,33


-9,39




Net income
Million USD		Released
Forecast
Spread 		-7,13
-6,14
-16.24%		-6,72
-7,20
6.73%		-7,26
-7,14
-1.67%		-7,55
-7,39
-2.13%		-6,80
-7,70
11.75%		-7,14
-6,99
-2.1%		-7,01
-7,34
4.39%		-7,82
-7,31
-6.99%		-8,06
-8,01
-0.7%
-8,07


-8,11


-8,92


-9,22




EPS
USD		Released
Forecast
Spread 		-0,70
-0,67
-5%		-0,50
-0,53
6.25%		-0,50
-0,49
-3.09%		-0,50
-0,49
-2.04%		-0,40
-0,51
21.57%		-0,42
-0,44
3.82%		-0,37
-0,41
9.76%		-0,40
-0,40
-0.84%		-0,40
-0,40
-1.27%
-0,22


-0,11


-0,12


-0,12


-0,14

Announcement Date10/03/2212/05/2211/08/2210/11/2223/03/2311/05/2308/08/2309/11/2321/03/24-----

Upcoming sector events for Regulus Therapeutics Inc

Today 21:00 MANNKIND CORPORATION: Q1 2024 Earnings Release
Today 21:00 CYTOKINETICS, INCORPORATED: Q1 2024 Earnings Release
Today 21:05 PROTHENA CORPORATION PLC: Q1 2024 Earnings Release
Today 21:05 REGENXBIO INC.: Q1 2024 Earnings Release
08/05/2024 STRUCTURE THERAPEUTICS INC.: Q1 2024 Earnings Release (Projected)
08/05/2024 PRIME MEDICINE, INC.: Q1 2024 Earnings Release (Projected)
08/05/2024 SAB BIOTHERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected)
08/05/2024 CABALETTA BIO, INC.: Q1 2024 Earnings Release (Projected)
08/05/2024 ALPINE IMMUNE SCIENCES, INC.: Q1 2024 Earnings Release (Projected)
08/05/2024 SAVARA INC.: Q1 2024 Earnings Release (Projected)
More events

Past sector events for Regulus Therapeutics Inc

Today ANAPTYSBIO, INC.: Q1 2024 Earnings Release (Projected)
Today RAPT THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected)
Today ALX ONCOLOGY HOLDINGS INC.: Q1 2024 Earnings Release (Projected)
Today 89BIO, INC.: Q1 2024 Earnings Release (Projected)
Today DYNAVAX TECHNOLOGIES CORPORATION: Q1 2024 Earnings Release
Today BEIGENE, LTD.: Q1 2024 Earnings Release
07/05/2024 21:01 DENALI THERAPEUTICS INC.: Q1 2024 Earnings Release
07/05/2024 21:01 HALOZYME THERAPEUTICS, INC.: Q1 2024 Earnings Release
07/05/2024 13:00 MOONLAKE IMMUNOTHERAPEUTICS: Q1 2024 Earnings Release
07/05/2024 13:00 COGENT BIOSCIENCES, INC.: Q1 2024 Earnings Release
  1. Stock Market
  2. Equities
  3. RGLS Stock
  4. Stock
  5. Calendar Regulus Therapeutics Inc